Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results matching your filters

Bevacizumab-based Chemotherapy Adapted to Bevacizumab Pharmacokinetics in 1st-line TreatmentRecruiting
NCT06642844Phase 3Updated Jun 16, 2026
Sponsor: University Hospital, Tours
Unresectable Metastatic Colorectal Cancer
France
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial CancerRecruiting
NCT06774131Phase 3Updated Jun 16, 2026
Sponsor: UroGen Pharma Ltd.
Upper Urinary Tract Urothelial Carcinoma · Urothelial Carcinoma
United States, Bulgaria, Georgia, Hungary, Israel +4 more
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia GravisRecruiting
NCT07463521Phase 3Updated Jun 16, 2026
Sponsor: UCB Biopharma SRL
Ocular Myasthenia Gravis
United States
Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)Recruiting
NCT07428499Phase 3Updated Jun 16, 2026
Sponsor: ADARx Pharmaceuticals, Inc.
Hereditary Angioedema (HAE) · Hereditary Angioedema - Type 1 · Hereditary Angioedema - Type 2 · HAE
United States, Argentina, Australia, Austria, Belgium +14 more
A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 InhibitorsRecruiting
NCT07404553Phase 2, Phase 3Updated Jun 16, 2026
Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd
Hypercholesterolemia
China
Radiotherapy After Prostatectomy for Node Positive Prostate CancerRecruiting
NCT07477626Phase 3Updated Jun 16, 2026
Sponsor: Sun Yat-sen University
Prostate Cancer (Post Prostatectomy) · Radiotherapy; Image-Guided · Prostate Cancer Non-Metastatic · Androgen Deprivation Therapy
China
STOP-HAE: A Phase 3 Study of ADX-324 in HAERecruiting
NCT06960213Phase 3Updated Jun 16, 2026
Sponsor: ADARx Pharmaceuticals, Inc.
Hereditary Angioedema · HAE · Hereditary Angioedema - Type 1 · Hereditary Angioedema - Type 2
United States, Argentina, Australia, Austria, Belgium +14 more
The Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1Recruiting
NCT06030843Phase 2, Phase 3Updated Jun 16, 2026
Sponsor: Chulalongkorn University
Empagliflozin in Cardiorenal Syndrome Type 1
Thailand
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal TumorsRecruiting
NCT05208047Phase 3Updated Jun 16, 2026
Sponsor: Cogent Biosciences, Inc.
Advanced Gastrointestinal Stromal Tumors · Metastatic Cancer
United States, Argentina, Australia, Brazil, Canada +17 more
Statins Study in Children of Acute Kawasaki Disease With Coronary Artery AbnormalitiesRecruiting
NCT07530640Phase 3Updated Jun 16, 2026
Sponsor: Children's Hospital of Fudan University
Kawasaki Disease · Coronary Artery Abnormalities
China
Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate CancerRecruiting
NCT07548164Phase 3Updated Jun 16, 2026
Sponsor: Memorial Sloan Kettering Cancer Center
Prostate Cancer
United States
A Study of SHR-1918 In Participants With HypertriglyceridemiaRecruiting
NCT07349615Phase 3Updated Jun 16, 2026
Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd
Hypertriglyceridemia
China
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic PhenotypeRecruiting
NCT07190209Phase 3Updated Jun 15, 2026
Sponsor: Sanofi
Chronic Obstructive Pulmonary Disease
United States, Argentina, Brazil, Canada, Chile +6 more
Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone LymphomaRecruiting
NCT06006117Phase 3Updated Jun 15, 2026
Sponsor: The Lymphoma Academic Research Organisation
Marginal Zone Lymphoma
Belgium, France, Germany, Italy, Portugal
A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)Recruiting
NCT07200908Phase 3Updated Jun 15, 2026
Sponsor: Mirum Pharmaceuticals, Inc.
Chronic Hepatitis D Infection
Austria, Czechia, France, Germany, Italy +5 more
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral NeuropathyRecruiting
NCT06628908Phase 3Updated Jun 15, 2026
Sponsor: Vertex Pharmaceuticals Incorporated
Diabetic Peripheral Neuropathic Pain
United States
Analgesic Effectiveness of Capsaicin 8% Cutaneous Patch in ChildrenRecruiting
NCT05997979Phase 3Updated Jun 15, 2026
Sponsor: University Hospital, Brest
Neuropathic Pain · Chronic Pain
France
Two Versus One Week Breast Radiotherapy (RT)Recruiting
NCT06960707Phase 3Updated Jun 15, 2026
Sponsor: Weill Medical College of Cornell University
Breast Cancer
United States
Alcohol Use Disorder and CannabidiolRecruiting
NCT05613608Phase 2, Phase 3Updated Jun 15, 2026
Sponsor: University of Colorado, Denver
Alcohol Use Disorder
United States
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic DysfunctionRecruiting
NCT07188805Phase 3Updated Jun 15, 2026
Sponsor: Bayer
Left Ventricular Systolic Dysfunction · Heart Failure (Pediatric)
United States, Argentina, Austria, Belgium, Brazil +18 more
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active SurveillanceRecruiting
NCT03769766Phase 3Updated Jun 15, 2026
Sponsor: University of Texas Southwestern Medical Center
Prostate Cancer
United States
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic PhenotypeRecruiting
NCT07190222Phase 3Updated Jun 15, 2026
Sponsor: Sanofi
Chronic Obstructive Pulmonary Disease
United States, Argentina, Australia, Brazil, Canada +9 more
Pivotal Study to Evaluate YL202 Versus Docetaxel in Patients With Locally Advanced or Metastatic EGFR Sensitive Mutation Non-Squamous Non-Small Cell Lung CancerRecruiting
NCT07416994Phase 3Updated Jun 15, 2026
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Non-Small Cell Lung Cancer
China
rhTNK-tPA for Acute Ischemic Stroke Under Simplified Imaging in the Extended Time WindowRecruiting
NCT07606807Phase 3Updated Jun 15, 2026
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Acute Ischemic Stroke
China
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)Recruiting
NCT06345729Phase 3Updated Jun 15, 2026
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer
United States, Argentina, Australia, Austria, Brazil +22 more

Previous page Next page